Identification of ω‐ or (ω‐1)‐Hydroxylated Medium‐Chain Acylcarnitines as Novel Urinary Biomarkers for CYP3A Activity
Authors:
- 6 September 2017
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 103 (5) , 879-887
Abstract
Quantitative models of endogenous metabolites are useful in predicting CYP3A‐mediated drug–drug interactions. This study aimed to identify novel predictive markers for the magnitude of CYP3A induction and inhibition in male and female subjects using an untargeted metabolomics approach. Here we report five ω‐ or (ω‐1)‐hydroxylated medium‐chain acylcarnitines as novel CYP3A4 markers. As CYP4 catalyzes the ω‐ or (ω‐1)‐hydroxylation of various medium‐chain fatty acids (MCFAs), recombinant enzyme assays were used to determine the ω‐ and (ω‐1)‐hydroxylation activities of CYP3A4, CYP4A11, and CYP4F2. CYP3A4 catalyzed ω‐ and (ω‐1)‐hydroxylated MCFAs with the lowest Km and highest Vmax/Km values. Finally, we derived a model to predict midazolam clearance using these markers and demonstrated that the predictive model including three ω‐ or (ω‐1)‐hydroxylated medium‐chain acylcarnitines, 6β‐OH cortisol, and gender as covariates shows reliable predictability (r2 = 0.894).Keywords
Funding Information
- National Research Foundation of Korea (NRF‐2010‐0009796)
This publication has 30 references indexed in Scilit:
- Global Metabolomics and Targeted Steroid Profiling Reveal That Rifampin, a Strong Human PXR Activator, Alters Endogenous Urinary Steroid MarkersJournal of Proteome Research, 2013
- An Inducible Cytochrome P450 3A4-Dependent Vitamin D Catabolic PathwayMolecular Pharmacology, 2012
- Medium-chain fatty acids: Functional lipids for the prevention and treatment of the metabolic syndromePharmacological Research, 2010
- Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separationsAnalytica Chimica Acta, 2009
- Predicting Drug–Drug Interactions: An FDA PerspectiveThe AAPS Journal, 2009
- Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytesNucleic Acids Research, 2009
- 4β‐Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half‐life of elimination after induction with rifampicinBritish Journal of Clinical Pharmacology, 2008
- Human Cytochrome P450 Family 4 Enzymes: Function, Genetic Variation and RegulationDrug Metabolism Reviews, 2007
- Metabolism of 4β-Hydroxycholesterol in HumansJournal of Biological Chemistry, 2002
- The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.Journal of Clinical Investigation, 1998